Urothelial Carcinoma
📧 Sign up to get email alerts when something new happens for Urothelial Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Pembrolizumab Plus CA-4948 for the Treatment of Patients With Progressive Metastatic Urothelial Cancer Despite Prior Immunotherapy [Phase 1]
Phase 1 clinical trial evaluating pembrolizumab in combination with CA-4948 for progressive metastatic urothelial cancer, currently recruiti…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma [Phase 1]
Phase 1 clinical trial update on QXL138AM assessing safety, pharmacokinetics, and preliminary efficacy in patients with solid tumors and mul…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Enfortumab Vedotin and Pembrolizumab in People With Bladder Cancer [Phase 2]
A Phase 2 clinical trial evaluating the combination of Enfortumab Vedotin and Pembrolizumab in patients with urothelial carcinoma is current…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction [Phase 1]
Phase 1 trial evaluating veliparib, paclitaxel, and carboplatin in patients with various metastatic or unresectable solid tumors and liver o…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Immune-Stromal Landscape in Muscle-Invasive Bladder Cancer
A ClinicalTrials.gov entry describes a study evaluating the immune-stromal landscape in muscle-invasive bladder cancer, sponsored by Assiut …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: SYS6002 vs Chemotherapy in Patients With Locally Advanced or Metastatic Urothelial Carcinoma [Phase 3]
A Phase 3 trial evaluating SYS6002 versus standard chemotherapy in locally advanced or metastatic urothelial carcinoma; the study is not yet…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Pembrolizumab in Muscle-invasive Bladder Cancer [Phase 2]
A Phase 2 clinical trial evaluating pembrolizumab for muscle-invasive bladder cancer and urothelial carcinoma is currently active but not re…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A Study of Two Dosing Schedules of Atezolizumab in Combination With Gemcitabine and Cisplatin as First-Line Treatment for Metastatic Bladder Cancer [Phase 2]
Phase 2 trial evaluating two dosing schedules of atezolizumab in combination with gemcitabine and cisplatin as first-line therapy for metast…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer [Phase 1]
Phase 1 clinical trial evaluating GB-4362 in combination with Enfortumab Vedotin and Pembrolizumab for urothelial carcinoma is currently rec…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors [Phase 1]
Pfizer's Phase 1 study PF-08046876 is recruiting adults with various advanced solid tumors to evaluate safety and dosing. The trial includes…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Neoadjuvant Nivolumab With and Without Urelumab in Cisplatin-Ineligible or Chemotherapy-refusing Patients With Muscle-Invasive Urothelial Carcinoma of the Bladder [Phase 2]
Phase 2 trial evaluating nivolumab with and without urelumab in cisplatin-ineligible or chemotherapy-refusing patients with muscle-invasive …
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors [Phase 1]
Phase 1 clinical trial update for IDE892 evaluating monotherapy and combination in MTAP-deleted advanced solid tumors. The study is currentl…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 clinical trial of ZM008, an anti-LLT1 antibody, given as a single agent and then in combination with toripalimab in patients with ad…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A) [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 substudy of pembrolizumab (MK-3475) and other investigational PD-1/PD-L1 agents in PD-1/PD-…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Care of the Urothelial Cancer Patient and Prospective Procurement of Urothelial Cancer Tissue
This ClinicalTrials.gov entry describes the NCI-sponsored study NCT02379429, a trial focusing on care of urothelial cancer patients and pros…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Trastuzumab in Combination With Serplulimab and Chemotherapy for the Treatment of HER2-overexpressing Unresectable Locally Advanced or Metastatic Biliary Tract Cancer or Urothelial Carcinoma After Failure of Standard Therapy [Phase 2]
A Phase 2 clinical trial evaluates trastuzumab in combination with serplulimab and chemotherapy for HER2-overexpressing unresectable locally…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4 [Phase 1]
Phase 1/1b trial evaluating RNDO-564 as a single agent or in combination with pembrolizumab in bladder cancer and nectin-4–associated solid …
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors [Phase 1]
Open-label Phase 1 study evaluating BL-M07D1 in HER2-expressing malignant solid tumors, with recruitment across several tumor types includin…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Diagnostic Values of Urothelial Carcinomas: Single-bolus Versus Split-bolus Computed Tomography Urography [NA]
Clinical trial update evaluating diagnostic values of single-bolus versus split-bolus CT urography for urothelial carcinoma. The study is sp…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: A Study to Investigate the Antitumor Activity, Safety, Tolerability, and Pharmacokinetics of BGB-A445 in Combination With Tislelizumab in Participants With Select Advanced Solid Tumors. [Phase 1, Phase 2]
A phase 1/2 clinical trial is evaluating the combination of BGB-A445 with tislelizumab in patients with select advanced solid tumors, includ…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung Cancer, and Hepatocellular Carcinoma, Treated With PD-1/PDL-1 Inhibitors
A clinical trial is investigating whether Galectin-3 levels predict outcomes in patients with renal cell carcinoma, urothelial carcinoma, no…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial update shows ALE.P03 as monotherapy being studied in adults with selected advanced or metastatic CLDN1+ solid tum…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Bio Clinical Collection of Urothelial Carcinoma
This clinical trial update describes the Bio Clinical Collection of Urothelial Carcinoma trial, sponsored by University Hospital, Toulouse, …
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Sonidegib and Pembrolizumab in Treating Patients With Advanced Solid Tumors [Phase 1]
This update reports on a Phase 1 trial testing the combination of sonidegib and pembrolizumab in patients with various advanced solid tumors…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors [Phase 1, Phase 2]
This clinical trial update reports that GI Innovation is studying GI-101 and GI-101A as single agents or in combination with pembrolizumab o…